Rahil Shah

Research Associate, In Vivo Pharmacology at TCR2 Therapeutics - Cambridge, MA, US

Rahil Shah's Contact Details
HQ
617-949-5200
Location
Arlington, Massachusetts, United States
Company
TCR2 Therapeutics
Rahil Shah's Company Details
TCR2 Therapeutics logo, TCR2 Therapeutics contact details

TCR2 Therapeutics

Cambridge, MA, US • 250 - 499 Employees
BioTech/Drugs

TCR² Therapeutics Inc. is a clinical-stage cell therapy company developing a pipeline of novel T cell therapies for patients suffering from solid tumors. The company is focused on the discovery and development of product candidates against novel and complex targets utilizing its proprietary T cell receptor (TCR) Fusion Construct T cells (TRuC®-T cells). The TRuC platform is designed to specifically recognize and kill cancer cells by harnessing signaling from the entire TCR, independent of human leukocyte antigens (HLA). For more information about TCR², please visit www.tcr2.com.

Cancer therapy T cell biology Immunology Molecular biology Biotech Biotech
Details about TCR2 Therapeutics
Frequently Asked Questions about Rahil Shah
Rahil Shah currently works for TCR2 Therapeutics.
Rahil Shah's role at TCR2 Therapeutics is Research Associate, In Vivo Pharmacology.
Rahil Shah's email address is ***@tcr2.com. To view Rahil Shah's full email address, please signup to ConnectPlex.
Rahil Shah works in the BioTech/Drugs industry.
Rahil Shah's colleagues at TCR2 Therapeutics are Vignesh Manikandan, Monica K., Thomas Liu, Urjita Tendolkar, Katherine Palu, Neva DiBlasi, Ruifang Wang and others.
Rahil Shah's phone number is 617-949-5200
See more information about Rahil Shah